Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study
JAK inhibitor discontinuation is primarily driven by inefficacy and side effects, with variations by drug. Further studies are needed to explore long-term safety.
Authors
- Sujata Ganguly
- Ameen Jubber (ORCID: https://orcid.org/0000-0002-3254-3566)
- Arumugam Moorthy
- Kirby I. Bland
Institutions
- University of Leicester (GB)
- Tamil Nadu Dr. M.G.R. Medical University (IN)
- University Hospitals of Leicester NHS Trust (GB)
Publication Details
- Journal
- Cureus
- Published
- 2025-11-28
- DOI
- https://doi.org/10.7759/cureus.98018
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00